Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Massari

Showing results (11-20 of 568) with videos related to

Pageof 57
Sort By:
Lancet (London, England)|December 17, 2023
Adjuvant treatment in renal cell carcinoma: a never-ending story?Veronica Mollica, Francesco Massari
The Lancet. Oncology|January 20, 2019
CheckMate 214 patient-reported outcomes: listening to our patientsFrancesco Massari, Vincenzo Di Nunno
Lancet (London, England)|December 23, 2017
Atezolizumab for platinum-treated metastatic urothelial carcinomaFrancesco Massari, Vincenzo Di Nunno
European Urology|April 17, 2018
Re: Jose Luis Perez-Gracia, Yohann Loriot, Jonathan E. Rosenberg, et al. Atezolizumab in Platinum-treated Locally Advanced or Metastatic Urothelial Carcinoma: Outcomes by Prior Number of Regimens. Eur Urol 2018;73:462-8Francesco Massari, Vincenzo Di Nunno
European Urology Oncology|June 20, 2020
Re: Bimal Bhindi, Jeffrey Graham, J. Connor Wells, et al. Deferred Cytoreductive Nephrectomy in Patients with Newly Diagnosed Metastatic Renal Cell Carcinoma. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2020.04.038: Cytoreductive Nephrectomy: To Whom and When?Veronica Mollica, Alessandro Rizzo, Francesco Massari
The Lancet. Oncology|June 4, 2021
Adjuvant immunotherapy in muscle-invasive urothelial carcinomaAlessandro Rizzo, Veronica Mollica, Francesco Massari
The New England Journal of Medicine|December 16, 2020
Avelumab Maintenance for Urothelial CarcinomaVeronica Mollica, Alessandro Rizzo, Francesco Massari
Future Oncology (London, England)|July 14, 2020
The pivotal role of TMPRSS2 in coronavirus disease 2019 and prostate cancerVeronica Mollica, Alessandro Rizzo, Francesco Massari
The New England Journal of Medicine|January 21, 2016
Chemohormonal Therapy in Hormone-Sensitive Prostate CancerChiara Ciccarese, Matteo Santoni, Francesco Massari
European Urology Oncology|November 18, 2020
Re: Maha Hussain, Joaquin Mateo, Karim Fizazi, et al. Survival with Olaparib in Metastatic Castration-resistant Prostate Cancer. N Engl J Med. In press. https://doi.org/10.1056/NEJMoa2022485Alessandro Rizzo, Veronica Mollica, Francesco Massari
Pageof 57

Showing results (11-20 of 568) with videos related to

Sort By:
Pageof 57
Lancet (London, England)|December 17, 2023
Adjuvant treatment in renal cell carcinoma: a never-ending story?Veronica Mollica, Francesco Massari
The Lancet. Oncology|January 20, 2019
CheckMate 214 patient-reported outcomes: listening to our patientsFrancesco Massari, Vincenzo Di Nunno
Lancet (London, England)|December 23, 2017
Atezolizumab for platinum-treated metastatic urothelial carcinomaFrancesco Massari, Vincenzo Di Nunno
European Urology|April 17, 2018
Re: Jose Luis Perez-Gracia, Yohann Loriot, Jonathan E. Rosenberg, et al. Atezolizumab in Platinum-treated Locally Advanced or Metastatic Urothelial Carcinoma: Outcomes by Prior Number of Regimens. Eur Urol 2018;73:462-8Francesco Massari, Vincenzo Di Nunno
European Urology Oncology|June 20, 2020
Re: Bimal Bhindi, Jeffrey Graham, J. Connor Wells, et al. Deferred Cytoreductive Nephrectomy in Patients with Newly Diagnosed Metastatic Renal Cell Carcinoma. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2020.04.038: Cytoreductive Nephrectomy: To Whom and When?Veronica Mollica, Alessandro Rizzo, Francesco Massari
The Lancet. Oncology|June 4, 2021
Adjuvant immunotherapy in muscle-invasive urothelial carcinomaAlessandro Rizzo, Veronica Mollica, Francesco Massari
The New England Journal of Medicine|December 16, 2020
Avelumab Maintenance for Urothelial CarcinomaVeronica Mollica, Alessandro Rizzo, Francesco Massari
Future Oncology (London, England)|July 14, 2020
The pivotal role of TMPRSS2 in coronavirus disease 2019 and prostate cancerVeronica Mollica, Alessandro Rizzo, Francesco Massari
The New England Journal of Medicine|January 21, 2016
Chemohormonal Therapy in Hormone-Sensitive Prostate CancerChiara Ciccarese, Matteo Santoni, Francesco Massari
European Urology Oncology|November 18, 2020
Re: Maha Hussain, Joaquin Mateo, Karim Fizazi, et al. Survival with Olaparib in Metastatic Castration-resistant Prostate Cancer. N Engl J Med. In press. https://doi.org/10.1056/NEJMoa2022485Alessandro Rizzo, Veronica Mollica, Francesco Massari
Pageof 57